Evidence map›Paper›PMID 12429831›Full record

ArticleMolecular biology of the cell2002

Identification of a novel type of cGMP phosphodiesterase that is defective in the chemotactic stmF mutants.

Marcel E Meima, Ricardo M Biondi, Pauline Schaap

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Analysis of cGMP Signaling in Dictyostelium.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  3. Forty-five years of cGMP research inMolecular biology of the cell · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Signaling pathways regulating Dictyostelium myosin II.Journal of muscle research and cell motility · 2002
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marcel E MeimaSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.
Ricardo M Biondi
Pauline Schaap
University of Dundee · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

StmF mutants are chemotactic mutants that are defective in a cGMP phosphodiesterase (PDE) activity. We identified a novel gene, PdeD, that harbors two cyclic nucleotide-binding domains and a metallo-beta-lactamase homology domain. Similar to stmF mutants, pdeD-null mutants displayed extensively streaming aggregates, prolonged elevation of cGMP levels after chemotactic stimulation, and reduced cGMP-PDE activity. PdeD transcripts were lacking in stmF mutant NP377, indicating that this mutant carries a PdeD lesion. Expression of a PdeD-YFP fusion protein in pdeD-null cells restored the normal cGMP response and showed that PdeD resides in the cytosol. When purified by immunoprecipitation, the PdeD-YFP fusion protein displayed cGMP-PDE activity, which was retained in a truncated construct that contained only the metallo-beta-lactamase domain.

Indexed as

3',5'-Cyclic-GMP PhosphodiesterasesAmino Acid SequenceAnimalsChemotaxisCyclic GMPDictyosteliumEnzyme ActivationGene Expression Regulation, DevelopmentalHumansMolecular Sequence DataMutationProtein Structure, TertiaryRecombinant Fusion ProteinsSequence Alignment3',5'-Cyclic-GMP PhosphodiesterasesCyclic GMPRecombinant Fusion Proteins

Identifiers

PMID12429831
PMCPMC133599
OpenAlexW2107787836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.